Health token MED skyrockets to $0.06: where to buy MediBloc

Health token MED skyrockets to $0.06: where to buy MediBloc

By Puskar Pande - min read

The MediBloc (MED) token is up by 11% in the past 24 hours and is poised for another leg of the rally

The MediBloc token has seen a strong price surge accompanied by rising volumes that could propel the price towards the $0.09 region if the bulls manage to sustain the current rally. The coin could then target the $0.1 region and beyond. The MED token could reward its early holders with handsome gains if the price uptrend continues in the future. 

How & where to buy MediBloc in the UK and elsewhere

For buying crypto tokens, you will need to register a trading account with a crypto exchange/broker platform. The account registration process is quick and simple. All you need to do is provide a username, password and email address. Then, verify the account by completing the Know Your Customer (KYC) process. You will need to provide copies of documents such as your driving license and utility bill to comply with the KYC regulation. At this stage, you can deposit funds and start trading. 

Please avoid using decentralised exchanges as they are unregulated. For your benefit, we have selected two of the best platforms where you can trade easily. 

What is MediBloc? 

The MediBloc network is built for the health industry. The native token MED will be used for governance purposes and to pay for access to medical services on different platforms. The MediBloc network helps to share personal medical data with complete privacy and full proof security. The data is encrypted and can be shared through its blockchain network Panacea. 

Should I buy MED today?

The MediBloc token is currently enjoying a strong rally fuelled by rising volumes. The coin could very well rally towards its ATH if the whales continue accumulating huge quantities of MED. The MED token has the potential to establish new highs if the current rally can be defended by bulls. 

This article is informational only—none of the contents should be construed as financial or investment advice.